These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 5448744)

  • 21. Lack of interaction between ibuprofen and warfarin.
    Penner JA; Abbrecht PH
    Curr Ther Res Clin Exp; 1975 Dec; 18(6):862-71. PubMed ID: 813951
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypoprothrombinemic effect of warfarin not influenced by ciprofloxacin.
    Rindone JP; Kelley CL; Jones WN; Garewal HS
    Clin Pharm; 1991 Feb; 10(2):136-8. PubMed ID: 2009731
    [No Abstract]   [Full Text] [Related]  

  • 23. Interaction between sulindac and warfarin: different results in normal subjects and in an unusual patient with a potassium-losing renal tubular defect.
    Loftin JP; Vesell ES
    J Clin Pharmacol; 1979; 19(11-12):733-42. PubMed ID: 536470
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dissociative effects of drugs on the extinction of conditioned suppression in the rat.
    Marriott AS
    Act Nerv Super (Praha); 1971; 13(2):73-4. PubMed ID: 5145596
    [No Abstract]   [Full Text] [Related]  

  • 25. Effect of erythromycin in patients receiving long-term warfarin therapy.
    Weibert RT; Lorentz SM; Townsend RJ; Cook CE; Klauber MR; Jagger PI
    Clin Pharm; 1989 Mar; 8(3):210-4. PubMed ID: 2706893
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of anaesthetics on mature infections of Schistosoma mansoni in the white mouse.
    Dickerson G
    Nature; 1965 May; 206(987):953-4. PubMed ID: 5839863
    [No Abstract]   [Full Text] [Related]  

  • 27. Decreased sensitivity to warfarin in patients with myxedema.
    Rice AJ; McIntosh TJ; Fouts JR; Brunk SF; Wilson WR
    Am J Med Sci; 1971 Oct; 262(4):211-5. PubMed ID: 5142577
    [No Abstract]   [Full Text] [Related]  

  • 28. Predicting the daily prothrombin time response to warfarin.
    Farrow L; Mungall D; Raskob G; Hull R
    Ther Drug Monit; 1990 May; 12(3):246-9. PubMed ID: 2349607
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ticrynafen-racemic warfarin interaction: hepatotoxic or stereoselective?
    O'Reilly RA
    Clin Pharmacol Ther; 1982 Sep; 32(3):356-61. PubMed ID: 7105625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Interaction of chronic daily warfarin therapy and rifampin.
    O'Reilly RA
    Ann Intern Med; 1975 Oct; 83(4):506-8. PubMed ID: 1166982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Interaction between warfarin and propafenone in healthy volunteer subjects.
    Kates RE; Yee YG; Kirsten EB
    Clin Pharmacol Ther; 1987 Sep; 42(3):305-11. PubMed ID: 3621785
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Potentiation of anticoagulant effect of warfarin by phenylbutazone.
    Aggeler PM; O'Reilly RA; Leong L; Kowitz PE
    N Engl J Med; 1967 Mar; 276(9):496-501. PubMed ID: 6018280
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of four commonly-used tranquillizers on low-speed driving performance tests.
    Betts TA; Clayton AB; Mackay GM
    Br Med J; 1972 Dec; 4(5840):580-4. PubMed ID: 4566100
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hereditary warfarin resistance. Investigation of a rare phenomenon.
    Alving BM; Strickler MP; Knight RD; Barr CF; Berenberg JL; Peck CC
    Arch Intern Med; 1985 Mar; 145(3):499-501. PubMed ID: 3977518
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of centrally acting drugs on exploratory behaviour in rats.
    Marriott AS; Spencer PS
    Br J Pharmacol Chemother; 1965 Oct; 25(2):432-41. PubMed ID: 5866723
    [No Abstract]   [Full Text] [Related]  

  • 36. Variation in the response of human beings to vitamin K1.
    Zieve PD; Solomon HM
    J Lab Clin Med; 1969 Jan; 73(1):103-10. PubMed ID: 5762156
    [No Abstract]   [Full Text] [Related]  

  • 37. Hereditary resistance to coumarin anticoagulant drugs in man and rat.
    O'Reilly RA; Pool JG; Aggeler PM
    Ann N Y Acad Sci; 1968 Jul; 151(2):913-31. PubMed ID: 4189970
    [No Abstract]   [Full Text] [Related]  

  • 38. Determination of plasma prothrombin level by Ca2+-dependent prothrombin activator (CA-1) during warfarin anticoagulation.
    Iwahashi H; Kimura M; Nakajima K; Yamada D; Morita T
    J Heart Valve Dis; 2001 May; 10(3):388-92. PubMed ID: 11380105
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical implications of enzyme induction.
    Breckenridge A; Orme M
    Ann N Y Acad Sci; 1971 Jul; 179():421-31. PubMed ID: 5285387
    [No Abstract]   [Full Text] [Related]  

  • 40. A self-medication program for cardiology inpatients.
    Buchanan EC; Brooks MR; Greenwood RB
    Am J Hosp Pharm; 1972 Nov; 29(11):928-34. PubMed ID: 4655001
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.